Measures · C09 in 2024 · Part C · HD2 Managing Chronic (Long Term) Conditions
Diabetes Care – Eye Exam
Chronic ConditionsHealth PlanSource: HEDIS
- What it measures
- Percent of plan members with diabetes who had an eye exam to check for damage from diabetes during the year.
- How it's calculated
- The percentage of diabetic MA enrollees age 18-75 with diabetes (type 1 and type 2) (denominator) who had an eye exam (retinal) performed during the measurement year (numerator).
- Data source
- HEDIS
- Measurement period
- 01/01/2022 – 12/31/2022
- Better when
- Higher
- Weight
- 1 (Process Measure)
- Star assignment
- Clustering
- Case-mix adjusted
- No
- In improvement measure
- Yes
- Used in CAI
- Yes
- HEDIS label
- Eye Exam for Patients with Diabetes (EED)
- Exclusions
Show
• Medicare members 66 years of age and older as of December 31 of the measurement year who meet either of the following: − Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. − Living long-term in an institution any time during the measurement year as identified by the LTI flag in the Monthly Membership Detail Data File. • Members 66 years of age and older as of December 31 of the measurement year (all product lines) with both frailty (Frailty Value Set) and advanced illness (Advanced Illness Value Set) during the measurement year. • Members receiving palliative care (Palliative Care Assessment Value Set; Palliative Care Encounter Value Set; Palliative Care Intervention Value Set) during the measurement year. (optional) Members who do not have a diagnosis of diabetes (Diabetes Value Set), in any setting, during the measurement year or the year prior to the measurement year and who had a diagnosis of polycystic ovarian syndrome, gestational diabetes or steroid-induced diabetes (Diabetes Exclusions Value Set), in any setting, during the measurement year or the year prior to the measurement year. Organizations that apply optional exclusions must exclude members from the denominator for all indicators. The denominator for all rates must be the same. If the member was included in the measure based on claim or encounter data, as described in the event/ diagnosis criteria, the optional exclusions do not apply because the member had a diagnosis of diabetes. Contracts whose enrollment was at least 500 but less than 1,000 as of the July 2022 enrollment report and having measure score reliability less than 0.7 are excluded. Contracts whose enrollment was less than 500 as of the July 2022 enrollment report are excluded from this measure.- Disaster policy
- Higher measure star (2023-2024) for contracts with 25% or more enrolled affected by 2022 disasters.
From the 2024 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.
How the 2028 cut points are projected
Each boundary moves by its median year-on-year change since 2019, capped at 5 points, the most CMS lets a non-survey cut point move in a year. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.
| Stars | Org type | 2027 | Projected 2028 | Move |
|---|---|---|---|---|
| 2★ | MA | 61 | 64 | +3 |
| 3★ | MA | 72 | 74 | +2 |
| 4★ | MA | 79 | 79 | 0 |
| 5★ | MA | 86 | 86 | 0 |
2024 star distribution
Not rated: Plan too new to be measured (93); Plan too small to be measured (83); Plan not required to report measure (59); No data available (32); Not enough data available (9)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2027 | MA | < 61 % | >= 61 % to < 72 % | >= 72 % to < 79 % | >= 79 % to < 86 % | >= 86 % |
| 2026 | MA | < 60 % | >= 60 % to < 72 % | >= 72 % to < 80 % | >= 80 % to < 86 % | >= 86 % |
| 2025 | MA | < 57 % | >= 57 % to < 70 % | >= 70 % to < 77 % | >= 77 % to < 83 % | >= 83 % |
| 2024 | MA | < 52 % | >= 52 % to < 65 % | >= 65 % to < 73 % | >= 73 % to < 81 % | >= 81 % |
| 2023 | MA | < 47 % | >= 47 % to < 61 % | >= 61 % to < 71 % | >= 71 % to < 79 % | >= 79 % |
| 2022 | MA | < 52 % | >= 52 % to < 62 % | >= 62 % to < 71 % | >= 71 % to < 79 % | >= 79 % |
| 2021 | MA | < 63% | >= 63% to < 69% | >= 69% to < 73% | >= 73% to < 78% | >= 78% |
| 2020 | MA | < 63% | ? 63% to < 69% | ? 69% to < 73% | ? 73% to < 78% | ? 78% |
| 2019 | MA | < 56% | ? 56% to < 64% | ? 64% to < 73% | ? 73% to < 80% | ? 80% |
| 2018 | MA | < 47% | ? 47% to < 59% | ? 59% to < 72% | ? 72% to < 81% | ? 81% |
| 2017 | MA | < 46% | ? 46% to < 61% | ? 61% to < 73% | ? 73% to < 81% | ? 81% |
| 2016 | MA | < 53% | ? 53% to < 65% | ? 65% to < 75% | ? 75% to < 82% | ? 82% |
| 2015 | MA | < 53% | ? 53% to < 60% | ? 60% to < 64% | ? 64% to < 77% | ? 77% |
Lowest-scoring contracts, 2024
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| H3015 Shared Health Dual Plus - DE H3015-001 (HMO D-SNP) | BlueCross BlueShield of Tennessee | — | 0 | 1 | — | 73 | 0% |
| H2034 Community Care | CareSource | 310 | 24 | 1 | 0 | 49 | 0% |
| H0034 Hamaspik, Inc. | Hamaspik of Rockland County, Inc. | 2,714 | 25 | 1 | — | 48 | 0% |
| H9900 Wellcare | Centene Corporation | — | 37 | 1 | — | 36 | 1% |
| H5965 Wellcare | Centene Corporation | 1,556 | 38 | 1 | — | 35 | 1% |
| H4676 Troy Medicare | Troy Holdings, Inc. | 1,654 | 39 | 1 | 0 | 34 | 1% |
| H2128 Wellcare by Allwell | Centene Corporation | — | 40 | 1 | — | 33 | 1% |
| H5374 Longevity Health Plan | Longevity Health Founders, LLC | 892 | 41 | 1 | — | 32 | 1% |
| H8711 Wellcare | Centene Corporation | 0 | 42 | 1 | −1 | 31 | 1% |
| H7559 Molina Healthcare of Virginia | Molina Healthcare, Inc. | — | 43 | 1 | — | 30 | 2% |
| H6067 CareFirst BlueCross BlueShield Medicare Advantage | CareFirst, Inc. | — | 43 | 1 | 0 | 30 | 2% |
| H2722 Primewell Health Services | Louisiana Health Service & Indemnity Company | — | 43 | 1 | — | 30 | 2% |
| H8458 Wellcare by Allwell | Centene Corporation | — | 44 | 1 | — | 29 | 2% |
| H7169 Wellcare By Allwell | Centene Corporation | — | 44 | 1 | — | 29 | 2% |
| H9976 Wellcare by Allwell | Centene Corporation | — | 46 | 1 | — | 27 | 2% |
| H7518 Wellcare | Centene Corporation | 3,236 | 46 | 1 | 0 | 27 | 2% |
| H2162 Wellcare | Centene Corporation | 0 | 47 | 1 | — | 26 | 3% |
| H8133 Blue Cross and Blue Shield of Texas | Health Care Service Corporation | 2,507 | 47 | 1 | −1 | 26 | 3% |
| H8553 Wellcare | Centene Corporation | — | 47 | 1 | — | 26 | 3% |
| H1862 Wellcare | Centene Corporation | 12,758 | 48 | 1 | — | 25 | 3% |
| H1848 Wellcare | Centene Corporation | — | 48 | 1 | 0 | 25 | 3% |
| H3047 Wellcare | Centene Corporation | — | 49 | 1 | 0 | 24 | 4% |
| H9761 Wellcare | Centene Corporation | — | 49 | 1 | — | 24 | 4% |
| H1353 Wellcare | Centene Corporation | — | 49 | 1 | −2 | 24 | 4% |
| H7175 Wellcare | Centene Corporation | — | 49 | 1 | −1 | 24 | 4% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2027 | C11 | Diabetes Care – Eye Exam | 01/01/2025 – 12/31/2025 | 1 | HEDIS |
| 2026 | C11 | Diabetes Care – Eye Exam | 01/01/2024 – 12/31/2024 | 1 | HEDIS |
| 2025 | C09 | Diabetes Care – Eye Exam | 01/01/2023 – 12/31/2023 | 1 | HEDIS |
| 2024 | C09 | Diabetes Care – Eye Exam | 01/01/2022 – 12/31/2022 | 1 | HEDIS |
| 2023 | C09 | Diabetes Care – Eye Exam | 01/01/2021 – 12/31/2021 | 1 | HEDIS |
| 2022 | C09 | Diabetes Care – Eye Exam | 01/01/2020 – 12/31/2020 | 1 | HEDIS |
| 2021 | C13 | Diabetes Care – Eye Exam | 01/01/2018 – 12/31/2018 | 1 | HEDIS |
| 2020 | C13 | Diabetes Care – Eye Exam | 01/01/2018 – 12/31/2018 | 1 | HEDIS |
| 2019 | C13 | Diabetes Care – Eye Exam | 01/01/2017 – 12/31/2017 | 1 | HEDIS |
| 2018 | C13 | Diabetes Care – Eye Exam | 01/01/2016 – 12/31/2016 | 1 | HEDIS |
| 2017 | C13 | Diabetes Care – Eye Exam | 01/01/2015 - 12/31/2015 | 1 | HEDIS |
| 2016 | C13 | Diabetes Care – Eye Exam | 01/01/2014 - 12/31/2014 | 1 | HEDIS |
| 2015 | C14 | Diabetes Care – Eye Exam | 01/01/2013 - 12/31/2013 | 1 | HEDIS |